Fig. 6From: A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cellsExpression of PD-1 in T cells following specific activation with MIL-38-CD3 BiTE. T cells were cultured with MIL-38-CD3 or a non-targeting BiTE CD3-PEG for 48 h, when PD-1 expression was measured within the CD3+ population by flow cytometryBack to article page